Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma

8 Nov 2017

Abstract excerpt

Currently, molecular markers are not used when determining the prognosis and treatment strategy for patients with hepatocellular carcinoma ( HCC ). In the present study, we proposed that the identification of common pro‐oncogenic pathways in primary tumors ( PT ) and adjacent non‐malignant tissues ( AT ) typically used to predict HCC patient risks may result in HCC biomarker discovery. We examined the genome‐wide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29117471
DOI: 10.1002/1878-0261.12153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 11 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinomaPMID 29117471Read ↗

Association between ribosomal protein gene dysregulation and tumor biodiversity of hepatocellular carcinomaSemantic proximity Read ↗

Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinomaSemantic proximity Read ↗

Identification and Evaluation of Metabolic mRNAs and Key miRNAs in Colorectal Cancer Liver MetastasisSemantic proximity Read ↗

Large-scale omics data reveal the cooperation of mutation-circRNA-miRNA-target gene network in liver cancer oncogenesis.Semantic proximity Read ↗

Prognostic Model Identification of Ribosome Biogenesis-Related Genes in Pancreatic Cancer Based on Multiple Machine Learning AnalysesSemantic proximity Read ↗

Unveiling the Promising Prognostic and Immunological Role of MRTO4 in Hepatocellular Carcinoma with Correlation to Immune InfiltratesSemantic proximity Read ↗

Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic ApproachSemantic proximity Read ↗

RPS27A is a Poor Prognostic Predictor for Hepatocellular Carcinoma via Interacting with METTL3-Mediated RNA ModificationsSemantic proximity Read ↗

Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinomaSemantic proximity Read ↗

Computational Inference of Gene Co-Expression Networks for the identification of Lung Carcinoma Biomarkers: An Ensemble Approach.Semantic proximity Read ↗

A lenvatinib-resistance-derived transcriptional program identifies metabolic identity remodeling associated with unfavorable survival in hepatocellular carcinomaSemantic proximity Read ↗

Gene Regulation Network and prognosis analyses of PCK1 in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.